Data from: Risk factors for possible REM sleep behavior disorder: a CLSA population-based cohort study
收藏DataCite Commons2025-05-01 更新2025-05-10 收录
下载链接:
https://datadryad.org/dataset/doi:10.5061/dryad.0k27q21
下载链接
链接失效反馈官方服务:
资源简介:
Objective: Idiopathic REM sleep behavior disorder (RBD) is a powerful
marker of prodromal neurodegenerative synucleinopathy, with 80% of
patients ultimately phenoconverting to defined disease. Several
environmental risk factors for RBD have been suggested, but associations
vary between studies. We assessed sociodemographic, socioeconomic and
clinical correlates of RBD in a 30,000-subject national cohort. Methods:
Subjects aged 45-85 years in Canada were collected as part of the Canadian
Longitudinal Study on Aging. Possible RBD (pRBD) was screened with the
RBD-1Q, a questionnaire with 94% specificity and 87% sensitivity. To
improve diagnostic reliability, subjects screening positive for apnea or
non-REM parasomnia (young onset pRBD), and subjects self-reporting
dementia or Parkinson’s disease were excluded. A series of
sociodemographic, life style and mental health variables were analysed
cross-sectionally. Potential correlates were assessed via multivariable
logistic regression. Results: Of 30,097 subjects, 958 (3.2%) had pRBD.
Male sex (OR=2.14 ,95%CI=[1.84, 2.49]) and lower education (OR=0.95 [0.92,
0.98] were associated with pRBD. pRBD subjects had smoked more (total
smoking years OR=1.006 [1.010, 1.011]) and were more likely to be
moderate-heavy drinkers (OR=1.25 [1.03, 1.50]). There was a strong
association between pRBD and self-reported antidepressant treatment for
depression (OR=2.76 [2.22, 3.44]), psychological distress (OR=1.52 [1.37,
1.69]), mental illness (OR=2.08 [1.79, 2.41]), and post-traumatic stress
disorder (OR=2.84 [2.55, 3.54]). Conclusions: Our study replicated
previous reported associations between pRBD and smoking, low education and
male sex, and found previously-unreported links with alcohol use and
psychological distress. The risk factors for pRBD differ from those
previously defined for neurodegenerative synucleinopathies.
提供机构:
Dryad
创建时间:
2019-01-31



